{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:10Z","timestamp":1761129010717},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T00:00:00Z","timestamp":1343001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0041205","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T22:11:52Z","timestamp":1343081512000},"page":"e41205","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mycobacterium tuberculosis Infection Interferes with HIV Vaccination in Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Lech","family":"Ignatowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Mazurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaniya","family":"Leepiyasakulchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Sk\u00f6ld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Hinkula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunilla","family":"K\u00e4llenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Pawlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,7,23]]},"reference":[{"key":"ref1","article-title":"AIDS epidemic update November 2009, UNAIDS, WHO"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.4161\/hv.8.1.18129","article-title":"Influenza vaccination for older adults.","author":"HK Talbot","year":"2012"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4049\/jimmunol.1004027","article-title":"Protein energy malnutrition impairs homeostatic proliferation of memory CD8 T cells.","volume":"188","author":"SS Iyer","year":"2012","journal-title":"J Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/adc.48.10.753","article-title":"Effects of measles on the immune response of Nigerian children.","volume":"48","author":"HC Whittle","year":"1973","journal-title":"Arch Dis Child"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(78)92403-0","article-title":"Impairment of the immune response to vaccination after acute malaria.","volume":"1","author":"WA Williamson","year":"1978","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/erv.10.16","article-title":"Suppression of vaccine responses by malaria: insignificant or overlooked?","volume":"9","author":"AJ Cunnington","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00006454-200005000-00010","article-title":"Effect of fever on the serum antibody response of Gambian children to <italic>Haemophilus influenzae<\/italic> type b conjugate vaccine.","volume":"19","author":"S Usen","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.1371\/journal.pntd.0000571","article-title":"Maternal infection with <italic>Trypanosoma cruzi<\/italic> and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines.","volume":"3","author":"N Dauby","year":"2009","journal-title":"PloS Negl Trop Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vetpar.2007.05.006","article-title":"Infection with parasitic nematodes confounds vaccination efficacy.","volume":"148","author":"JF Urban Jr","year":"2007","journal-title":"Vet Parasitol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(10)60409-6","article-title":"The HIV-associated tuberculosis epidemic-when will we act?","volume":"375","author":"AD Harries","year":"2010","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection.","volume":"8","author":"A Pawlowski","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/IAI.01126-10","article-title":"HIV\/<italic>M. tuberculosis<\/italic> co-infection immunology: How does HIV exacerbate TB?","volume":"79","author":"CR Diedrich","year":"2011","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/CMR.14.4.753-777.2001","article-title":"Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.","volume":"14","author":"SD Lawn","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/cir900","article-title":"Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.","volume":"54","author":"A Cingolani","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref15","first-page":"247","article-title":"Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. J Gen Virol.","volume":"92","author":"K Poropatich","year":"2011"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2796.2008.02054.x","article-title":"Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.","volume":"265","author":"D Masopust","year":"2009","journal-title":"J Intern Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/QAD.0b013e3283377a1e","article-title":"HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, multifunctional T-cell responses.","volume":"24","author":"RE Owen","year":"2010","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/COH.0b013e32833d2d45","article-title":"Strategies for eliciting HIV-1 inhibitory antibodies.","volume":"5","author":"GD Tomaras","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref19","first-page":"e1001251","article-title":"Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog.","volume":"7","author":"I Mikell","year":"2011"},{"key":"ref20","first-page":"157","article-title":"Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.","volume":"354","author":"IM Belyakov","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/COH.0b013e32833d2cc0","article-title":"New approaches to design HIV-1 T-cell vaccines.","volume":"5","author":"H Perrin","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/COH.0b013e32833d17ac","article-title":"HIV vaccines: lessons learned and the way forward.","volume":"5","author":"JH Kim","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/592507","article-title":"Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.","volume":"198","author":"E Sandstr\u00f6m","year":"2008","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0105-2896.2006.00400.x","article-title":"Th1 memory: implications for vaccine development.","volume":"211","author":"KE Foulds","year":"2006","journal-title":"Immunol Rev"},{"key":"ref26","first-page":"362","article-title":"Curr Opin HIV AIDS","volume":"5","year":"2010"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1267126","DOI":"10.1021\/js980092e","article-title":"Selective augmentation of antibodies in various mucosal regions, after intranasal immunization with diphtheria in mice.","volume":"87","author":"S Gizurarson","year":"1998","journal-title":"J Pharm Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1099\/vir.0.004614-0","article-title":"Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons.","volume":"90","author":"WA Burgers","year":"2009","journal-title":"J Gen Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.106.5.703","article-title":"Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections I. Protective effects.","volume":"106","author":"RJ Dubos","year":"1957","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1084\/jem.106.5.719","article-title":"Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections. II. Enhancement of infection.","volume":"106","author":"RW Schaedler","year":"1957","journal-title":"J Exp Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/IAI.72.5.2598-2604.2004","article-title":"Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis.","volume":"72","author":"S Nookala","year":"2004","journal-title":"Infect Immun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.vaccine.2004.09.038","article-title":"<italic>Schistosoma mansoni<\/italic> infection reduces the protective efficacy of BCG vaccination against virulent <italic>Mycobacterium tuberculosis<\/italic>.","volume":"23","author":"D Elias","year":"2005","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0035-9203(80)90095-4","article-title":"The immune response to a meningococcal polysaccharide vaccine in an African village.","volume":"74","author":"BM Greenwood","year":"1980","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/00034983.1985.11811963","article-title":"Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination.","volume":"79","author":"AM Bradley-Moore","year":"1985","journal-title":"Ann Trop Med Parasitol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0035-9203(62)90005-6","article-title":"Antibody response to tetanus toxoid inoculation in malarious and non-malarious Gambian children.","volume":"56","author":"IA McGregor","year":"1962","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1365-3156.2009.02326.x","article-title":"Severe malaria and concomitant bacteraemia in children admitted to a rural Mozambican hospital.","volume":"14","author":"Q Bassat","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref37","first-page":"233","article-title":"Effect of <italic>Plasmodium falciparum<\/italic> malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.","volume":"365","author":"JG Kublin","year":"2005","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e10328","DOI":"10.1371\/journal.pone.0010328","article-title":"Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment.","volume":"5","author":"E Sartono","year":"2010","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI13603","article-title":"Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection.","volume":"111","author":"MK Slifka","year":"2003","journal-title":"J Clin Invest"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2249.2004.02719.x","article-title":"Low dose chronic <italic>Schistosoma mansoni<\/italic> infection increases susceptibility to <italic>Mycobacterium bovis<\/italic> BCG infection in mice.","volume":"139","author":"D Elias","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-3024.2006.00901.x","article-title":"Co-infection of helminths and malaria: modulation of the immune responses to malaria.","volume":"28","author":"FC Hartgers","year":"2006","journal-title":"Parasite Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/IAI.69.3.1574-1580.2001","article-title":"Human infection with <italic>Ascaris lumbricoides<\/italic> is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.","volume":"69","author":"PJ Cooper","year":"2001","journal-title":"Infect Immun"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JCM.40.6.2141-2146.2002","article-title":"Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.","volume":"40","author":"RA Subbramanian","year":"2002","journal-title":"J Clin Microbiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","article-title":"Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.","volume":"164","author":"AM Thornton","year":"2000","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","article-title":"Mechanisms of suppression by suppressor T cells.","volume":"6","author":"H von Boehmer","year":"2005","journal-title":"Nat Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/cmi.2010.39","article-title":"Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells.","volume":"7","author":"G Hu","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tube.2010.05.003","article-title":"Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis.","volume":"90","author":"ND Marin","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.178.5.2661","article-title":"Cutting Edge: Regulatory T cells prevent efficient clearance of <italic>Mycobacterium tuberculosis<\/italic>.","volume":"178","author":"M Kursar","year":"2007","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2006.11.009","article-title":"CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress <italic>Mycobacterium tuberculosis<\/italic> immunity in patients with active disease.","volume":"123","author":"X Chen","year":"2007","journal-title":"Clin Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1128\/JVI.76.24.12596-12602.2002","article-title":"Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.","volume":"76","author":"C Balmelli","year":"2002","journal-title":"J Virol"},{"key":"ref51","article-title":"Global tuberculosis control: a short update to the 2009 report. Geneva: World Health Organization.","year":"2009"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.0903856","article-title":"Understanding latent tuberculosis: a moving target.","volume":"185","author":"PL Lin","year":"2010","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/ng.815","article-title":"Estimating the mutation rate of <italic>Mycobacterium tuberculosis<\/italic> during infection.","volume":"43","author":"DR Sherman","year":"2011","journal-title":"Nat Genet"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of <italic>Mycobacterium tuberculosis<\/italic> during latent infection.","volume":"43","author":"CB Ford","year":"2011","journal-title":"Nat Genet"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s15010-008-8087-y","article-title":"A dynamic reinfection hypothesis of latent tuberculosis infection.","volume":"37","author":"PJ Cardona","year":"2009","journal-title":"Infection"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","article-title":"Experimental <italic>Mycobacterium tuberculosis<\/italic> infection of cynomolgus macaques closely resembles the various manifestations of human <italic>M. tuberculosis<\/italic> infection.","volume":"71","author":"SV Capuano","year":"2003","journal-title":"Infect Immun"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model.","volume":"77","author":"PL Lin","year":"2009","journal-title":"Infect Immun"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/429825","article-title":"High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.","volume":"40","author":"L Mtei","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref59","article-title":"Diagnostics for tuberculosis: global demand and market potential. WHO.","author":"J Cunningham","year":"2006"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"<italic>Mycobacterium tuberculosis<\/italic> arabinomannan-protein conjugates protect against tuberculosis.","volume":"21","author":"B Hamasur","year":"2003","journal-title":"Vaccine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/IAI.05552-11","article-title":"Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to <italic>Mycobacterium tuberculosis<\/italic>.","volume":"80","author":"C Leepiyasakulchai","year":"2012","journal-title":"Infect Immun"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1016\/j.vaccine.2005.08.015","article-title":"A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations.","volume":"24","author":"J Hinkula","year":"2006","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1016\/j.vaccine.2008.08.060","article-title":"Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.","volume":"26","author":"A Br\u00e5ve","year":"2008","journal-title":"Vaccine"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1515\/BC.1999.049","article-title":"DNA-plasmids of HIV-1 induce systemic and mucosal immune responses.","volume":"380","author":"Y Asakura","year":"1999","journal-title":"Biol Chem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0264-410X(98)00404-6","article-title":"Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA.","volume":"17","author":"P Lundholm","year":"1999","journal-title":"Vaccine"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-1759(00)00141-1","article-title":"Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents.","volume":"238","author":"C Devito","year":"2000","journal-title":"J Immunol Methods"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.173.11.7078","article-title":"Intranasal HIV-1-gp160-DNA\/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.","volume":"173","author":"C Devito","year":"2004","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0041205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:49:02Z","timestamp":1588974542000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0041205"}},"subtitle":[],"editor":[{"given":"Thomas Jens","family":"Scriba","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,23]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0041205","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,23]]}}}